Search results for "pharmaceutical company"

Biogen Korea Taps Pharma Veteran Kim Chul-woong as New Country Lead

Biogen Korea Taps Pharma Veteran Kim Chul-woong as New Country Lead

Biogen Korea has appointed Kim Chul-woong as its new general manager, tapping an executive with extensive expertise in rare and intractable diseases...
Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal

Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal

Samsung Biologics is making a major push into peptide-based medicines—widely used in weight-loss and diabetes therapies—through the planned...
31 Bottles Per Person: Kwangdong Corn Silk Tea Marks 20th Anniversary With 1.6 Billion Bottles Sold

31 Bottles Per Person: Kwangdong Corn Silk Tea Marks 20th Anniversary With 1.6 Billion Bottles Sold

For South Koreans looking for a refreshing, caffeine-free beverage, it is a staple that almost everyone has tried at...
Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch

Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch

Daewoong Pharmaceutical announced on the 13th that its flagship botulinum toxin product, Nabota, surpassed 1 trillion...
Daewoong’s Enblo Demonstrates Strong Potential to Reverse Fatty Liver in Diabetes Patients

Daewoong’s Enblo Demonstrates Strong Potential to Reverse Fatty Liver in Diabetes Patients

Daewoong Pharmaceutical announced that its newly developed type 2 diabetes medication, Enblo (active ingredient:...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem

MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem

South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for...
Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio

Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio

Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology...
Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo

Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo

Daewoong Pharmaceutical’s proprietary type 2 diabetes treatment, Enblo (active ingredient: enavogliflozin), is set to...
Dongkook Pharmaceutical Secures 39 Billion Won Latin American Export Deal for BPH Treatment Uresco

Dongkook Pharmaceutical Secures 39 Billion Won Latin American Export Deal for BPH Treatment Uresco

Waking up frequently at night to urinate or noticing a weaker urine stream is a common health concern for men as they...